A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.

After purchasing for research at the National Institutes of Health was put on hold last week, employees have now been told they can continue working with some current vendors, according to a memo obtained by CNN.